Home > Healthcare > Pharmaceuticals > Finished Drug Form > Joint Pain Injections Market
Joint Pain Injections Market Share
- Report ID: GMI5403
- Published Date: Mar 2023
- Report Format: PDF
Joint Pain Injections Market Share
Some of the major market players operating in the joint pain injection industry is :
- The Zimmer Biomet
- Anika Therapeutics, Inc.
- Bioventus
- Sanofi
- Pacira Biosciences (Flexion)
- OrthogenRx
- Pfizer
- Ferring B.V.
- Lifecore Biomedical
- Wright Medical Group (Stryker)
- Emcyte Corporation
- Stryker
Market players are focusing on the introduction of Visco supplements.
Frequently Asked Questions (FAQ) :
Global market size for joint pain injections stood at over USD 3.5 billion in 2022 and is anticipated to showcase more than 8.5% CAGR from 2023 to 2032 owing to a significant rise in the prevalence of musculoskeletal conditions and orthopedic disorders.
Joint pain injection industry size from the hospital segment is expected to amass over USD 5.4 billion by 2032 owing to the easy accessibility to advanced medical equipment and skilled orthopedic surgeons across these facilities.
North America joint pain injection market is projected to witness more than 7.5% CAGR between 2023 and 2032 driven by the consistent rise in the geriatric population and strong competitive landscape across the region.
Prominent enterprises operating in the global market include Zimmer Biomet, Anika Therapeutics, Inc., Bioventus, Sanofi, Pfizer, and others
Joint Pain Injections Market Scope
×
Get a free sample of
Joint Pain Injections Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below